The Federal Supply Schedule contract awarded to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, provides a range of molecular diagnostic products and services to the U.S. Department of Veterans Affairs (VA). Under this multiple-award contract, Abbott Molecular will supply equipment, reagents, and testing capabilities related to sexually transmitted infections (STIs) and SARS-CoV-2 on the Alinity M platform. The $2,683,875.95 firm-fixed-price delivery order, awarded by the VA's Veterans Integrated Service Network 4, has a performance period through December 2029 and does not utilize any set-asides. As a leading provider of molecular diagnostics to federal agencies, Abbott Molecular has an extensive track record of supplying clinical testing platforms, consumables, and support services to the VA, Centers for Disease Control and Prevention, and Department of the Army. The company's diverse healthcare portfolio, which includes cardiovascular devices, nutritional products, and rapid COVID-19 tests, positions it as a significant supplier to federal healthcare programs, supporting patient care across multiple medical specialties. Abbott Laboratories, the parent company of Abbott Molecular, holds several other Indefinite Delivery Vehicles with federal agencies, including a $150,000 single-award contract with the VA's Veterans Integrated Service Network 23 for histology reagents, a $107 million Indefinite Delivery Contract with the VA National Acquisition Center for dietary supplements and tube feeding products, and two Blanket Purchase Agreements with the Defense Health Agency valued at $249,999 and $250,000 for specialized food and nutrition supplements. These long-term partnerships demonstrate Abbott's commitment to providing critical medical products and nutritional supplies to support patient care in government healthcare facilities.
Mod # | Description | Reason For Modification | Federal Obligation (Click to sort descending) | Date (Click to sort ascending) |
|---|---|---|---|---|
| P00001 | Add Subcontract Plan | $0 | 2/20/25 | |
| Not listed | Not listed | $0 | 8/30/24 |
Name | Description | Awardee | Potential Value (Click to sort descending) | Award Date (Click to sort descending) | Completion Date (Click to sort descending) | Updated At (Click to sort descending) |
|---|---|---|---|---|---|---|
Delivery Order 36F79724D0201-36C24424F0564 | Abbott Molecular Inc. | $2.7m | 9/13/24 | 9/12/25 | 9/13/24 |